These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

985 related articles for article (PubMed ID: 17128305)

  • 21. Percutaneous coronary revascularization of diabetic patients in the era of drug-eluting stents.
    Kereiakes DJ; Young JJ
    Rev Cardiovasc Med; 2005; 6 Suppl 1():S48-58. PubMed ID: 15665798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examining the economic impact of restenosis: implications for the cost-effectiveness of an antiproliferative stent.
    Greenberg D; Cohen DJ
    Z Kardiol; 2002; 91 Suppl 3():137-43. PubMed ID: 12641029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. State of the art: coronary artery stents - past, present and future.
    Stefanini GG; Byrne RA; Windecker S; Kastrati A
    EuroIntervention; 2017 Aug; 13(6):706-716. PubMed ID: 28844032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis.
    Siontis GC; Stefanini GG; Mavridis D; Siontis KC; Alfonso F; Pérez-Vizcayno MJ; Byrne RA; Kastrati A; Meier B; Salanti G; Jüni P; Windecker S
    Lancet; 2015 Aug; 386(9994):655-64. PubMed ID: 26334160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary balloon angioplasty, stents, and scaffolds.
    Byrne RA; Stone GW; Ormiston J; Kastrati A
    Lancet; 2017 Aug; 390(10096):781-792. PubMed ID: 28831994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy.
    Tanaka K; Li H; Curran PJ; Takano Y; Arbit B; Currier JW; Yeatman LA; Kobashigawa JA; Tobis JM
    Am J Cardiol; 2006 Apr; 97(8):1192-7. PubMed ID: 16616025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of unprotected left main coronary artery disease with drug-eluting stents: is it time for a randomized trial?
    Chieffo A; Colombo A
    Nat Clin Pract Cardiovasc Med; 2005 Aug; 2(8):396-400. PubMed ID: 16119701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Coronary angioplasty in elderly patients].
    Liistro F; Colombo A
    Ital Heart J Suppl; 2002 Jan; 3(1):1-8. PubMed ID: 11899566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Stents in interventional cardiology].
    Grinius V; Navickas R; Unikas R
    Medicina (Kaunas); 2007; 43(3):183-9. PubMed ID: 17413246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
    Stone GW; Ellis SG; Cannon L; Mann JT; Greenberg JD; Spriggs D; O'Shaughnessy CD; DeMaio S; Hall P; Popma JJ; Koglin J; Russell ME;
    JAMA; 2005 Sep; 294(10):1215-23. PubMed ID: 16160130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
    Meads C; Cummins C; Jolly K; Stevens A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(23):1-153. PubMed ID: 11074393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention.
    Yeh RW; Normand SL; Wolf RE; Jones PG; Ho KK; Cohen DJ; Cutlip DE; Mauri L; Kugelmass AD; Amin AP; Spertus JA
    Circulation; 2011 Oct; 124(14):1557-64. PubMed ID: 21900079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
    Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
    JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting stents: from bench to bed.
    Waksman R
    Cardiovasc Radiat Med; 2002; 3(3-4):226-41. PubMed ID: 12974379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes and coronary revascularization.
    Flaherty JD; Davidson CJ
    JAMA; 2005 Mar; 293(12):1501-8. PubMed ID: 15784875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-stent restenosis.
    Kim MS; Dean LS
    Cardiovasc Ther; 2011 Jun; 29(3):190-8. PubMed ID: 20406239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-eluting stent: the emerging technique for the prevention of restenosis.
    Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
    Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug-eluting balloon in the treatment of a recurrent in-stent restenosis of drug-eluting stent].
    Merkely B; Jambrik Z
    Orv Hetil; 2010 Sep; 151(37):1509-14. PubMed ID: 20807698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.